- Home
- CNSP vs GMEX Comparison
CNSP vs GMEX Comparison
Compare CNSP & GMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.26
N/A
Current Price
$0.93
Company Overview
Basic Information| Metric | CNSP | GMEX |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 1.7M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CNSP | GMEX |
|---|---|---|
| Price | $2.26 | $0.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 29.5K | ★ 61.3K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | ★ 148.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $0.89 |
| 52 Week High | $10.59 | $1.18 |
Technical Indicators
Market Signals| Indicator | CNSP | GMEX |
|---|---|---|
| Relative Strength Index (RSI) | 26.57 | N/A |
| Support Level | $0.77 | N/A |
| Resistance Level | $4.00 | N/A |
| Average True Range (ATR) | 0.33 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 9.65 | 0.00 |
Price Performance
Historical Comparison CNSP
GMEX
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.